Similar articles

• [Platelet aggregation in multiple sclerosis (author's transl)].

  Prosiegel M, Neu I, Pfaffenrath V, Nahme M. Prosiegel M, et al. Nervenarzt. 1982 Apr;53(4):227-30. Nervenarzt. 1982. PMID: 7099309 German. No abstract available.
• Platelet hyperaggregability in multiple sclerosis.

  Couch JR, Hassanein RS. Couch JR, et al. Trans Am Neurol Assoc. 1977;102:62-4. Trans Am Neurol Assoc. 1977. PMID: 616117 No abstract available.
• Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside.

  Cendrowski W. Cendrowski W. Acta Neurol Belg. 1973 Jul-Aug;73(4):209-19. Acta Neurol Belg. 1973. PMID: 4770124 No abstract available.
• [Cytochemical characteristics of nucleic acids in the peripheral blood lymphocytes of patients with multiple sclerosis].

  Grechukh AM. Grechukh AM. Zh Nevropatol Psikhiatr Im S S Korsakova. 1976;76(5):672-4. Zh Nevropatol Psikhiatr Im S S Korsakova. 1976. PMID: 936868 Russian.
• [Characteristic standard values for the kinetics of thrombocyte aggregation in platelet-containing plasma].

  Holzhüter H, Angelkort B, Wenzel E, Hermans W, Koch N, Lenartz H. Holzhüter H, et al. Verh Dtsch Ges Inn Med. 1974;80:1436-9. Verh Dtsch Ges Inn Med. 1974. PMID: 4454448 German. No abstract available.